| Literature DB >> 24523701 |
Frank K Hu1, Shuchang He2, Zhiwei Fan2, Juan Lupiáñez3.
Abstract
Attention deficits are prominent among the core symptoms of schizophrenia. A recent meta-analysis has suggested that patients with schizophrenia have a deficit in endogenous disengagement of attention. In this research, we used a standard spatial cueing paradigm to examine whether the attention deficit of such patients is due to impaired attentional disengagement or defective novelty detection/habituation processes. In a spatial cueing procedure with peripheral non-predictive cues and a detection task, we manipulated the valence of either the cue or the target (i.e., a threatening vs. scrambled face) in two separate experiments. The control group exhibited a smaller inhibition of return (IOR) effect only when the target had an emotional load, not when the cue had an emotional load. In the patient group, a larger emotional effect appeared when the threatening face was the target; by contrast, no effect of valence was observed when the threatening face was the cue: IOR was delayed or completely absent independently of valence. The present findings are in conflict with the hypothesis that IOR is due to the disengagement of attention and the subsequent inhibition to return. Instead, they seem to suggest a cost in detecting new information at a previously cued location. From this perspective, it seems that patients with schizophrenia might have a deficit in detecting new information and considering it as new in the current context.Entities:
Keywords: disengagement; habituation/detection cost; inhibition of return; schizophrenia
Year: 2014 PMID: 24523701 PMCID: PMC3905237 DOI: 10.3389/fpsyt.2014.00007
Source DB: PubMed Journal: Front Psychiatry ISSN: 1664-0640 Impact factor: 4.157
Characteristics of the groups studied in Experiment 1 (patients with schizophrenia and control participants).
| Participants’ characteristics | Schizophrenia ( | Healthy controls ( | ||
|---|---|---|---|---|
| Age (years) | 34.0 (1.64) | 22.8 (0.611) | 5.67 | 0.001 |
| Gender (female ratio) | 20/20 | 9/15 | 3.06 | 0.009 |
| Education level (years) | 9.30 (0.603) | 13.8 (0.296) | 6.05 | 0.001 |
| Right-handedness | 20/20 | 15/15 | ||
| Length of illness (years) | 11.55 (1.86) |
Standard error (SE) is shown in brackets for age, education level, and length of illness.
Figure 1Schematic of procedure used in the spatial cueing task. Each trial had the following sequence: fixation, initial display, cue, inter stimulus interval (ISI), target, and response. The picture shows an example of a cued trial with a threatening face target (not drawn exactly to scale).
Figure 2Target detection times of Experiment 1, broken down by Cueing (cued vs. uncued location), Cue Valence (threatening vs. neutral), and Stimulus Onset Asynchrony (SOA). Left panel: patient group; right panel: control group.
Mean reaction times (ms) and. accuracy as a function of Cue Valence (threatening vs. neutral), Cueing (valid vs. invalid), and SOA in Experiment 1.
| SOA | ||||||||
|---|---|---|---|---|---|---|---|---|
| 380 | 580 | 880 | 1280 | |||||
| Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | |
| Control neutral cue | 344.98 (11.66) | 367.20 (10.24) | 321.09 (13.71) | 349.00 (11.10) | 319.37 (12.28) | 356.71 (13.90) | 327.91 (11.37) | 352.68 (13.01) |
| Control threatening cue | 343.60 (11.23) | 371.33 (12.37) | 318.48 (10.46) | 351.36 (11.95) | 323.24 (12.53) | 361.06 (12.55) | 328.75 (13.29) | 352.79 (12.57) |
| Patient neutral cue | 562.40 (30.95) | 571.25 (26.12) | 571.54 (31.35) | 570.70 (27.58) | 536.40 (29.67) | 568.49 (29.88) | 543.86 (30.78) | 553.85 (29.67) |
| Patient threatening cue | 571.11 (29.34) | 573.47 (26.80) | 564.21 (29.67) | 576.16 (26.44) | 548.97 (30.98) | 552.14 (26.59) | 542.25 (29.11) | 565.05 (28.08) |
| Control neutral cue | 0.99 (0.01) | 1.00 (0.00) | 0.99 (0.01) | 0.99 (0.01) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) |
| Control threatening cue | 1.00 (0.00) | 0.99 (0.01) | 0.99 (0.01) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) |
| Patient neutral cue | 0.93 (0.03) | 0.89 (0.03) | 0.91 (0.02) | 0.93 (0.02) | 0.91 (0.03) | 0.92 (0.02) | 0.92 (0.02) | 0.91 (0.03) |
| Patient threatening cue | 0.89 (0.03) | 0.88 (0.04) | 0.93 (0.02) | 0.93 (0.02) | 0.94 (0.02) | 0.93 (0.03) | 0.93 (0.02) | 0.94 (0.02) |
Standard error (SE) is shown in brackets.
Characteristics of the groups studied in Experiment 2 (patients with schizophrenia and control participants).
| Participants’ characteristics | Schizophrenia ( | Healthy controls ( | ||
|---|---|---|---|---|
| Age (years) | 33.6 (1.77) | 23.3 (0.733) | 5.40 | 0.001 |
| Gender (female ratio) | 10/20 | 10/15 | 0.98 | 0.336 |
| Education level (years) | 8.50 (0.387) | 13.27 (0.267) | 9.45 | 0.001 |
| Right-handedness | 20/20 | 15/15 | ||
| Length of illness (years) | 12.02 (1.59) |
Standard error (SE) is shown in brackets for age, education level, and length of illness.
Figure 3Target detection times of Experiment 2, broken down by Cueing (cued vs. uncued location), Target valence (threatening vs. neutral), and Stimulus Onset Asynchrony (SOA). Left panel: patient group; right panel: control group.
Mean reaction times (ms) and accuracy as a function of target valence (threatening vs. neutral), Cueing (valid vs. invalid), and SOA in Experiment 2.
| SOA | ||||||||
|---|---|---|---|---|---|---|---|---|
| 380 | 580 | 880 | 1280 | |||||
| Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | Cue_invalid | Cue_valid | |
| Control neutral target | 350.27 (9.93) | 372.43 (8.78) | 342.17 (15.61) | 366.02 (13.21) | 325.28 (11.17) | 363.71 (13.88) | 347.65 (10.52) | 372.43 (11.51) |
| Control threatening target | 354.18 (12.09) | 368.21 (8.90) | 334.41 (14.82) | 355.73 (11.67) | 333.68 (13.35) | 361.62 (11.98) | 341.37 (12.40) | 364.96 (11.89) |
| Patient neutral target | 516.78 (20.81) | 535.63 (23.24) | 504.63 (21.38) | 522.48 (22.58) | 501.49 (24.32) | 524.58 (24.28) | 503.41 (24.20) | 511.27 (22.47) |
| Patient threatening target | 494.74 (20.42) | 494.78 (21.48) | 494.17 (25.41) | 502.62 (22.95) | 494.84 (23.55) | 482.89 (20.81) | 472.51 (21.41) | 498.14 (23.15) |
| Control neutral target | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) |
| Control threatening target | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) | 1.00 (0.00) |
| Patient neutral target | 0.96 (0.01) | 0.95 (0.02) | 0.96 (0.02) | 0.98 (0.01) | 0.97 (0.02) | 0.95 (0.02) | 0.97 (0.02) | 0.96 (0.02) |
| Patient threatening target | 0.97 (0.01) | 0.97 (0.01) | 0.94 (0.02) | 0.98 (0.01) | 0.97 (0.01) | 0.98 (0.01) | 0.96 (0.01) | 0.96 (0.02) |
Standard error (SE) is shown in brackets.
| df | |||
|---|---|---|---|
| SOA | (2, 72) | 8.25 | 0.000** |
| Cueing | (1, 33) | 18.59 | 0.000** |
| Cue Valence | (1, 33) | 0.80 | 0.377 |
| Group | (1, 33) | 41.26 | 0.000** |
| SOA*Cueing | (3, 99) | 1.09 | 0.358 |
| SOA*Cue Valence | (2, 78) | 0.17 | 0.878 |
| SOA*Group | (3, 99) | 4.47 | 0.005** |
| Cueing*Cue Valence | (1, 33) | 0.00 | 0.991 |
| Cueing*Group | (1, 33) | 3.67 | 0.064 |
| Cue Valence*Group | (1, 33) | 0.01 | 0.915 |
| SOA*Cueing*Cue Valence | (3, 99) | 2.06 | 0.110 |
| SOA*Cueing*Group | (3, 99) | 0.49 | 0.687 |
| SOA*Cue Valence*Group | (3, 99) | 0.33 | 0.807 |
| Cueing*Cue Valence*Group | (1, 33) | 0.27 | 0.608 |
| SOA*Cueing*Cue Valence*Group | (3, 99) | 1.87 | 0.140 |
| df | |||
|---|---|---|---|
| SOA | (2, 68) | 10.72 | 0.000** |
| Cueing | (1, 33) | 33.48 | 0.000** |
| Cue Valence | (1, 33) | 1.96 | 0.171 |
| SOA*Cueing | (3, 99) | 1.58 | 0.199 |
| SOA*Cue Valence | (3, 99) | 0.13 | 0.941 |
| SOA*Group | (3, 99) | 5.35 | 0.002** |
| Cueing*Cue Valence | (1, 33) | 0.02 | 0.897 |
| Cueing*Group | (1, 33) | 9.40 | 0.004** |
| Cue Valence*Group | (1, 33) | 0.07 | 0.795 |
| SOA*Cueing*Cue Valence | (3, 99) | 1.51 | 0.216 |
| SOA*Cueing*Group | (3, 99) | 0.69 | 0.562 |
| SOA*Cue Valence*Group | (3, 99) | 0.50 | 0.684 |
| Cueing*Cue Valence*Group | (1, 33) | 0.34 | 0.565 |
| SOA*Cueing*Cue Valence*Group | (3, 99) | 1.37 | 0.257 |
| df | |||
|---|---|---|---|
| SOA | (2, 74) | 3.18 | 0.042* |
| Cueing | (1, 33) | 22.58 | 0.000** |
| Target Valence | (1, 33) | 24.89 | 0.000** |
| Group | (1, 33) | 31.67 | 0.000** |
| SOA*Cueing | (3, 99) | 0.34 | 0.799 |
| SOA*Target Valence | (3, 99) | 0.34 | 0.796 |
| SOA*Group | (3, 99) | 1.61 | 0.191 |
| Cueing*Target Valence | (1, 33) | 3.11 | 0.087 |
| Cueing*Group | (1, 33) | 3.12 | 0.087 |
| Target Valence*Group | (1, 33) | 14.21 | 0.001** |
| SOA*Cueing*Target Valence | (3, 99) | 2.52 | 0.063 |
| SOA*Cueing*Group | (3, 99) | 0.90 | 0.445 |
| SOA*Target Valence*Group | (3, 99) | 2.02 | 0.116 |
| Cueing*Target Valence*Group | (1, 33) | 0.36 | 0.551 |
| SOA*Cueing*Target Valence*Group | (3, 99) | 1.21 | 0.312 |
| df | |||
|---|---|---|---|
| SOA | (2, 72) | 4.57 | 0.011* |
| Cueing | (1, 33) | 24.55 | 0.000** |
| Target Valence | (1, 33) | 31.83 | 0.000** |
| SOA*Cueing | (3, 99) | 0.48 | 0.695 |
| SOA*Target Valence | (3, 99) | 0.56 | 0.641 |
| SOA*Group | (3, 99) | 2.11 | 0.104 |
| Cueing*Target Valence | (1, 33) | 2.92 | 0.097 |
| Cueing*Group | (1, 33) | 6.72 | 0.014* |
| Target Valence*Group | (1, 33) | 13.97 | 0.001** |
| SOA*Cueing*Target Valence | (3, 99) | 2.28 | 0.084 |
| SOA*Cueing*Group | (3, 99) | 1.10 | 0.352 |
| SOA*Target Valence*Group | (3, 99) | 2.04 | 0.113 |
| Cueing*Target Valence*Group | (1, 33) | 0.12 | 0.728 |
| SOA*Cueing*Target Valence*Group | (3, 99) | 0.81 | 0.492 |